Response to Dr. Stuart Newman's commentary on an article entitled "Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen".
Brent
R L
RL
Department of Pediatrics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
D000818:Animals; D000932:Antiemetics / Q000009:adverse effects*; D004025:Dicyclomine; D004319:Doxylamine / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007603:Jurisprudence; D011247:Pregnancy; D011736:Pyridoxine / Q000009:adverse effects*; D013723:Teratogens / Q000633:toxicity*
D000932:Antiemetics; D004338:Drug Combinations; D013723:Teratogens; C004454:dicyclomine, doxylamine, pyridoxine drug combination; D004025:Dicyclomine; D004319:Doxylamine; D011736:Pyridoxine